Healthcare › Healthcare Plans
CVS Health
- Ticker
- CVS
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Healthcare Plans
Price data arrives in a later stage, so no price is shown yet.
Latest news
ImportantCVS
Explain this story: MinuteClinic is helping connect more Americans to care
MinuteClinic is expanding access to care by offering affordable and convenient in-person, virtual, and digital health options, addressing issues like long wait times and high costs. It provides services ranging from acute illness treatment and preventive care to chronic condition management and weight loss support. The initiative also aims to help close the primary care gap by offering accessible ongoing care through its clinics and virtual platforms.
OtherCVS HealthSector and industry: HealthcareHealthcare PlansTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
MinuteClinic is expanding access to care by offering affordable and convenient in-person, virtual, and digital health options, addressing issues like long wait times and high costs. It provides services ranging from acute illness treatment and preventive care to chronic condition management and weight loss support. The initiative also aims to help close the primary care gap by offering accessible ongoing care through its clinics and virtual platforms.
Article tone: Positive This describes the words the journalist used. It is not a prediction, and not advice.
Company newsCVS
Explain this story: Why McKesson Stock Soared More Than 5% Higher Today
McKesson stock gained over 5% after announcing an extension of its long-standing partnership with CVS Health until June 2032. The agreement ensures McKesson will continue distributing medicines to CVS's various pharmacy operations. McKesson also reaffirmed its fiscal year 2027 and long-term earnings guidance, highlighting its strong position in the healthcare distribution market.
OtherYahoo FinanceSector and industry: HealthcareHealthcare Plans
Company newsCVS
Explain this story: Mckesson Corp Stock (MCK) Moved Up by 4.52% on Oct 1: What Investors Need To Know
McKesson Corp (MCK) saw its stock rise by 4.52% on October 1st, driven by the extension of its pharmaceutical distribution contract with CVS Health through June 2032. The company also reaffirmed its fiscal 2027 adjusted earnings outlook and long-term growth targets, with annual revenue of $403.43 billion and a net profit of $4.76 billion. Despite regulatory scrutiny and thin distribution margins, this long-term agreement enhances investor confidence and provides revenue predictability for the healthcare logistics firm.
OtherTradingKeyHealthcare
Company newsCVS
Explain this story: Why Is Cardinal Health and McKesson Stock Trading Higher Today - CVS Health (NYSE:CVS), McKesson (NYSE:MC
Cardinal Health (NYSE: CAH) and McKesson Corporation (NYSE: MCK) both saw their stock trading higher after extending their pharmaceutical distribution agreements with CVS Health (NYSE: CVS) through June 2032. Cardinal Health reaffirmed its fiscal year 2027 adjusted earnings growth guidance and long-term EPS growth rate, while McKesson reiterated its fiscal 2027 adjusted earnings outlook and long-term EPS growth rate. This comes as Aetna, a CVS Health subsidiary, expands its prior authorization bundles for cancer treatments.
OtherBenzinga
ImportantCVS
Explain this story: CVS Health declares quarterly dividend of $0.665 per share By Investing.com
CVS Health has announced that its board of directors approved a quarterly dividend of $0.665 per share on the company’s common stock. The dividend is scheduled to be paid on November 2, 2026, to shareholders of record as of October 22, 2026. The company operates a vast network of retail pharmacies, walk-in clinics, and provides health insurance products, serving millions of individuals.
OtherInvesting.com India
ImportantCVS
Explain this story: CVS Health Keeps Quarterly Dividend at $0.665 cents Per Share; Payable Nov. 2 to Shareholders of Record on Oct. 22
CVS Health has announced it will maintain its quarterly dividend at $0.665 cents per share. This dividend is scheduled to be paid on November 2nd to shareholders who are on record as of October 22nd. The company's stock information and recent news are also provided, alongside its profile detailing its healthcare services and segments.
Othermarketscreener.com
ImportantCVS
Explain this story: CVS Health declares quarterly dividend
CVS Health's board of directors has approved a quarterly dividend of $0.665 per share on the company's Common Stock. This dividend is scheduled to be paid on November 2, 2026, to shareholders who are on record by October 22, 2026. CVS Health is highlighted as a leading health solutions company, providing retail pharmacy locations, medical clinics, and pharmacy benefits management services.
OtherPR NewswireHealthcare
Company newsHAL
Explain this story: Is Halliburton (NYSE:HAL) Stock Worth Watching Today?
Halliburton (NYSE:HAL) is worth watching due to service demand influenced by crude oil volatility and its impact on drilling budgets. The broader market is characterized by selective trading, emphasizing business quality, operating consistency, and sector-specific demand amidst fluctuating interest rates, energy prices, and global trade discussions. The article highlights the importance of company-specific execution and demand signals to assess Halliburton's performance within the nuanced oil and gas sector.
OtherKalkine MediaEnergy
Company newsSLB
Explain this story: Is SLB (NYSE:SLB) Stock Worth Watching Today?
SLB (NYSE:SLB) is currently in focus due to oilfield activity amidst easing crude prices and moderating supply concerns. The article emphasizes that the broader market remains selective, prioritizing business quality and consistent operations, making company-specific execution crucial for oil and gas stocks. Future clarity on SLB's performance will depend on upcoming company communications regarding demand, operations, and sector conditions.
OtherKalkine MediaSector and industry: Energy
Company newsABBV
Explain this story: Is AbbVie (NYSE:ABBV) Stock Worth Watching Today?
AbbVie (NYSE:ABBV) is a relevant stock to watch today as defensive healthcare demand supports the sector. The market is selective, focusing on business quality and execution amid varied macroeconomic factors like interest rates, energy prices, and technology interest. The company's business model durability and customer demand signals will be key in understanding its performance within the current market environment.
OtherKalkine MediaSector and industry: HealthcareDrug Manufacturers
Elsewhere
These links open other websites. We do not provide price data yet.